The objective of the trial is to evaluate the safety and efficacy of JMT101 in patients with advanced solid tumor.~This study consists of two parts (Stage I and Stage II). Stage I was a dose escalation study, and Stage II was a dose expansion study.
This study is a Phase I, open label, multi-center study of to evaluate the safety and efficacy of JMT101 in patients with advanced solid tumor.